82_FR_32849 82 FR 32714 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

82 FR 32714 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 135 (July 17, 2017)

Page Range32714-32714
FR Document2017-14856

Federal Register, Volume 82 Issue 135 (Monday, July 17, 2017) 
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Notices]
[Page 32714]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-14856]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group; Acquired Immunodeficiency Syndrome Research 
Review Committee AIDS.
    Date: August 10-11, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Robert C. Unfer, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3F40A, National Institutes of Health, NIAID, 5601 
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5035, 
robert.unfer@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-14856 Filed 7-14-17; 8:45 am]
BILLING CODE 4140-01-P

32714 Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices of tricyclic compounds blocking malaria Place: National Institutes of Health, 5601 Agenda: To review and evaluate grant parasite oocyst development and Fishers Lane, Rockville, MD 20892 applications. transmission. Antimicrob. Agents (Telephone Conference Call). Place: National Institutes of Health, 5601 Contact Person: Robert C. Unfer, Ph.D., Fishers Lane, Rockville, MD 20892 Chemother. 57: 425–435. Scientific Review Officer, Scientific Review (Telephone Conference Call). Intellectual Property: US Patent # Program, Division of Extramural Activities, Contact Person: Louis A. Rosenthal, Ph.D., 9,375,424, US divisional patent Room 3F40A, National Institutes of Health, Scientific Review Officer, Immunology application: 13/392,668, Worldwide NIAID, 5601 Fishers Lane, MSC 9834, Review Branch, 5601 Fishers Lane, patent applications: Canada 2772085, Bethesda, MD 20892–9834, (240) 669–5035, Telephone: 240–669–5070, Fax: 301–480– Europe 10812670.7, India 1684/DELNP/ robert.unfer@nih.gov. 2408, rosenthalla@niaid.nih.gov. 2012. Priority Application 61/237,417 (Catalogue of Federal Domestic Assistance Name of Committee: National Institute of filed August 27, 2009. (HHS Reference Program Nos. 93.855, Allergy, Immunology, Allergy and Infectious Diseases Special and Transplantation Research; 93.856, Emphasis Panel; NIAID Clinical Trial No. E–283–2009) Implementation Grant (R01). Microbiology and Infectious Diseases Licensing Contact: Peter Tung, Ph.D.; Research, National Institutes of Health, HHS) Date: August 10, 2017. 240–669–5483; peter.tung@nih.gov. Time: 1:00 p.m. to 2:30 p.m. Dated: July 10, 2017. Agenda: To review and evaluate grant Collaborative Research Opportunity: Natasha M. Copeland, applications. The National Institute of Allergy and Place: National Institutes of Health, 5601 Infectious Diseases is seeking statements Program Analyst, Office of Federal Advisory Committee Policy. Fishers Lane, Rockville, MD 20892 of capability or interest from parties (Telephone Conference Call). interested in collaborative research to [FR Doc. 2017–14856 Filed 7–14–17; 8:45 am] Contact Person: Roberta Binder, Ph.D., further develop, evaluate or BILLING CODE 4140–01–P Scientific Review Officer, Scientific Review commercialize this technology. For Program, Division of Extramural Activities, collaboration opportunities, please Room 3G21A, National Institutes of Health/ contact Peter Tung; 240–669–5483; DEPARTMENT OF HEALTH AND NIAID, 5601 Fishers Lane, MSC 9823, peter.tung@nih.gov. HUMAN SERVICES Bethesda, MD 20892–9823, (240) 669–5050, rbinder@niaid.nih.gov. Dated: July 6, 2017. National Institutes of Health (Catalogue of Federal Domestic Assistance Suzanne Frisbie, Program Nos. 93.855, Allergy, Immunology, Deputy Director, Technology Transfer and National Institute of Allergy and and Transplantation Research; 93.856, Intellectual Property Office, National Institute Infectious Diseases; Notice of Closed Microbiology and Infectious Diseases of Allergy and Infectious Diseases. Meetings Research, National Institutes of Health, HHS) [FR Doc. 2017–14861 Filed 7–14–17; 8:45 am] Dated: July 10, 2017. Pursuant to section 10(d) of the BILLING CODE 4140–01–P Federal Advisory Committee Act, as Natasha M. Copeland, amended (5 U.S.C. App.), notice is Program Analyst, Office of Federal Advisory hereby given of the following meetings. Committee Policy. DEPARTMENT OF HEALTH AND [FR Doc. 2017–14855 Filed 7–14–17; 8:45 am] HUMAN SERVICES The meetings will be closed to the public in accordance with the BILLING CODE 4140–01–P National Institutes of Health provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institute of Allergy and as amended. The grant applications and DEPARTMENT OF HEALTH AND Infectious Diseases; Notice of Closed the discussions could disclose HUMAN SERVICES Meeting confidential trade secrets or commercial National Institutes of Health property such as patentable material, Pursuant to section 10(d) of the and personal information concerning Center for Scientific Review; Notice of Federal Advisory Committee Act, as individuals associated with the grant Closed Meetings amended (5 U.S.C. App.), notice is applications, the disclosure of which hereby given of the following meeting. would constitute a clearly unwarranted Pursuant to section 10(d) of the The meeting will be closed to the invasion of personal privacy. Federal Advisory Committee Act, as public in accordance with the amended (5 U.S.C. App.), notice is Name of Committee: National Institute of hereby given of the following meetings. provisions set forth in sections Allergy and Infectious Diseases Special 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meetings will be closed to the Emphasis Panel; NIAID Clinical Trial as amended. The grant applications and Planning Grant (R34). public in accordance with the the discussions could disclose Date: August 8, 2017. provisions set forth in sections confidential trade secrets or commercial Time: 1:15 p.m. to 2:30 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., property such as patentable material, Agenda: To review and evaluate grant as amended. The grant applications and and personal information concerning applications. the discussions could disclose individuals associated with the grant Place: National Institutes of Health, 5601 confidential trade secrets or commercial Fishers Lane, Rockville, MD 20892 property such as patentable material, applications, the disclosure of which (Telephone Conference Call). would constitute a clearly unwarranted and personal information concerning Contact Person: Louis A. Rosenthal, Ph.D., individuals associated with the grant invasion of personal privacy. Scientific Review Officer, Immunology asabaliauskas on DSKBBXCHB2PROD with NOTICES Review Branch, 5601 Fishers Lane, applications, the disclosure of which Name of Committee: Microbiology, would constitute a clearly unwarranted Infectious Diseases and AIDS Initial Review Telephone: 240–669–5070, Fax: 301–480– Group; Acquired Immunodeficiency 2408, rosenthalla@niaid.nih.gov. invasion of personal privacy. Syndrome Research Review Committee Name of Committee: National Institute of Name of Committee: Center for Scientific AIDS. Allergy and Infectious Diseases Special Review Special Emphasis Panel; Member Date: August 10–11, 2017. Emphasis Panel; NIAID Clinical Trial Conflict: International and Cooperative Time: 8:00 a.m. to 6:00 p.m. Planning Grant (R34). Projects 1. Agenda: To review and evaluate grant Date: August 8, 2017. Date: July 21, 2017. applications. Time: 12:00 p.m. to 1:15 p.m. Time: 10:30 a.m. to 12:00 p.m. VerDate Sep<11>2014 17:45 Jul 14, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\17JYN1.SGM 17JYN1


Document Created: 2017-07-15 03:45:47
Document Modified: 2017-07-15 03:45:47
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesAugust 10-11, 2017.
FR Citation82 FR 32714 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR